Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will assess transcranial magnetic stimulation (TMS) as a biomarker and
characterize TMS readouts of the activity of MK2637 and dextromethorphan. Resting
quantitative electroencephalography(qEEG) readouts are also characterized with MK2637 and
dextromethorphan.